Luke Schulz

Luke Schulz is an experienced pharmaceutical professional currently serving as Site Lead at Curium Pharma since November 2018, overseeing the largest single site for Gallium PSMA and Technetium doses production. Schulz has successfully managed multiple inspections and holds various regulatory licenses, contributing to production performance optimization, SOP development, and compliance with safety and legal standards. Additionally, Schulz is an Honorary Lecturer in the Department of Pharmacy and Pharmacology at the University of the Witwatersrand and has a background as a Nuclear Pharmacist at AXIM, where responsibilities included radiolabelling and quality control. Previous roles also include Core Territory Manager at Johnson & Johnson and several pharmacy positions, complemented by academic credentials including a Bachelor of Pharmacy and an Executive Leadership Programme from the University of Oxford.